- Home
- RNST vs SRRK Comparison
RNST vs SRRK Comparison
Compare RNST & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNST
- SRRK
- Stock Information
- Founded
- RNST 1904
- SRRK 2012
- Country
- RNST United States
- SRRK United States
- Employees
- RNST N/A
- SRRK N/A
- Industry
- RNST Major Banks
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RNST Finance
- SRRK Health Care
- Exchange
- RNST Nasdaq
- SRRK Nasdaq
- Market Cap
- RNST 3.3B
- SRRK 3.2B
- IPO Year
- RNST N/A
- SRRK 2018
- Fundamental
- Price
- RNST $35.48
- SRRK $36.36
- Analyst Decision
- RNST Buy
- SRRK Strong Buy
- Analyst Count
- RNST 6
- SRRK 7
- Target Price
- RNST $42.20
- SRRK $42.17
- AVG Volume (30 Days)
- RNST 588.6K
- SRRK 1.2M
- Earning Date
- RNST 07-22-2025
- SRRK 08-06-2025
- Dividend Yield
- RNST 2.48%
- SRRK N/A
- EPS Growth
- RNST N/A
- SRRK N/A
- EPS
- RNST 2.24
- SRRK N/A
- Revenue
- RNST $735,631,000.00
- SRRK N/A
- Revenue This Year
- RNST $41.67
- SRRK N/A
- Revenue Next Year
- RNST $12.79
- SRRK $1,960.31
- P/E Ratio
- RNST $15.88
- SRRK N/A
- Revenue Growth
- RNST 17.24
- SRRK N/A
- 52 Week Low
- RNST $26.97
- SRRK $6.76
- 52 Week High
- RNST $39.63
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- RNST 39.21
- SRRK 46.15
- Support Level
- RNST $35.79
- SRRK $36.96
- Resistance Level
- RNST $37.92
- SRRK $39.13
- Average True Range (ATR)
- RNST 0.89
- SRRK 1.69
- MACD
- RNST -0.34
- SRRK -0.59
- Stochastic Oscillator
- RNST 8.39
- SRRK 9.08
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.